Perrigo Co PLC
Fermé
SecteurSoins de santé
9.76 2.74
Résumé
Variation du prix de l'action
24h
Min
9.47
Max
9.82
Revenu | 1B -390M |
|---|---|
Ventes | -140M 969M |
BPA | 0.43 |
Rendement du dividende | 11.32 |
Marge bénéficiaire | -40.229 |
Employés | 8,100 |
EBITDA | 962M -284M |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +79.14% upside |
Rendement du dividende Moyenne du Secteur | 11.32% 2.41% |
|---|---|
Prochains Résultats | 5 août 2026 |
Date du Prochain Dividende | 15 sept. 2026 |
Date du Prochain Détachement de Dividende | 28 août 2026 |
Capitalisation Boursière | -239M 1.3B |
|---|---|
Ouverture précédente | 7.02 |
Clôture précédente | 9.76 |
Sentiment de l'Actualité
By Acuity
28%
72%
74 / 342 Classement par Healthcare
Perrigo Co PLC Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Perrigo Co PLC
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.